DM3
Product Specifications
Product Name Alternative
Maytansinoid DM3
UNSPSC Description
Target Antigen
ADC Cytotoxin; Microtubule/Tubulin
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage;Cytoskeleton
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dm3.html
Purity
95.59
Solubility
DMSO : 100 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
C[C@]12[C@H]([C@@H]([C@](O3)([H])C[C@]([C@](/C=C/C=C(C)/CC4=CC(N(C)C(C[C@]2([H])OC([C@H](C)N(C)C(CCC(S)C)=O)=O)=O)=C(C(OC)=C4)Cl)([H])OC)(NC3=O)O)C)O1
Molecular Weight
766.34
References & Citations
[1]Chen H, et al. Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy. Molecules. 2017 Aug 1;22(8).
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-130080/DM3-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-130080/DM3-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
796073-54-6
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CECR5, ID (Cat Eye Syndrome Critical Region Protein 5) (PE)
